Patterns of medical resource and psychotropic medicine use among adult depressed managed behavioral health patients

Journal of Behavioral Health Services and Research

Volumn 31, Issue 1, 2004, Pages 26-37

  Azocar, Francisca ^a   McCarter, Loren M ^a   Cuffel, Brian J ^a   Croghan, Thomas W ^b  

^a United Behavioral Health   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; COMORBIDITY; DEPRESSION; FEMALE; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL SPECIALIST; MENTAL HEALTH CARE; PHARMACY; PRACTICE GUIDELINE; ECONOMICS; MENTAL HEALTH SERVICE; MIDDLE AGED; STATISTICS; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MANAGED CARE PROGRAMS; MENTAL HEALTH SERVICES; MIDDLE AGED; PSYCHOTROPIC DRUGS;

EID: 1442279503     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02287336     Document Type: Article

References (52)

1. Regier DA, Goldberg ID, Taube CA. The de facto US mental health services system: a public health perspective. Archives of General Psychiatry. 1978;35(6):685-693.
2. Wells KB, Sturm R, Sherbourne CD, et al. Caring for Depression. London, England: Harvard University Press; 1996.
3. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States results from the national comorbidity survey. Archives of General Psychiatry. 1994;51:8-19.
4. Findlay S. Trends: managed behavioral health care in 1999: An industry at a crossroads. Health Affairs. 1999;18(5):116-124.
5. Goldman W. Is there a shortage of psychiatrists? Psychiatric Services. In press.
6. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medications. Journal of the American Medical Association. 1998;279(7):526-531.
7. Katzelnick DJ, Simon GE, Pearson SD, et al. Randomized trial of a depression management program in high utilizers of medical care. Archives of Family Medicine. 2000;9(4):345-351.
8. Simon GE, Katon WJ, VonKorff M, et al. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. American Journal of Psychiatry. October 2001;158(10):1638-1644.
9. Katon W, Von Korff M, Lin EH, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. Journal of the American Medical Association. 1995;273(13):1026-1031.
10. Lin EH, Katon WJ, Simon GE, et al. Achieving guidelines for the treatment of depression in primary care: is physician education enough? Medical Care. 1997;35(8):831-842.
11. Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Archives of General Psychiatry. 1999;56(12):1109-1115.
12. Cuffel BJ, Goldman W, Schlesinger H. Does managing behavioral health care services increase the cost of providing medical care? Journal of Behavioral Health Services & Research. 1999;26(4):371-379.
13. Sturm R, Goldman W, McCulloch J. Mental health and substance abuse parity: a case study of Ohio's state employees program. The Journal of Mental Health and Economics. 1998;1:129-134.
14. Goldman W, McCulloch J, Sturm R. Costs and use of mental health services before and after managed care. Health Affairs. 1998;17(2):40-52.
15. Huskamp HA. How a managed behavioral health care carve-out plan affected spending for episodes of treatment. Psychiatric Services. 1998;49(12):1559-1562.
16. Miranda J, Arean PA, Rickman RL. Relationship of mental and medical disorders in primary care. In: Miranda J, Hohmann AA, Attkisson CC, Larson DB, ed. Mental Disorders in Primary Care. San Francisco: Jossey-Bass; 1994:93-108.
17. Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. American Journal of Psychiatry. 1988;145(8):976-981.
18. Katon W, Egan K, Miller D. Chronic pain: lifetime psychiatric diagnoses and family history. American Journal of Psychiatry. 1985;142(10):1156-1160.
19. Katon W. The development of a randomized trial of consultation-liaison psychiatry in distressed high utilizers of primary care. Psychiatric Medicine. 1991;9:577-591.
20. Katon W, Sullivan M, Walker E. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Annals of Internal Medicine. 2001;134(9, pt 2):917-925.
21. Walker EA, Gelfand AN, Gelfand MD, et al. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychological Medicine. 1995;25(6):1259-1267.
22. Walker EA, Keegan D, Gardner G, et al. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis, I: psychiatric diagnoses and functional disability. Psychosomatic Medicine. 1997;59(6):565-571.
23. Kisely S, Goldberg D, Simon G. A comparison between somatic symptoms with and without clear organic cause: results of an international study. Psychological Medicine. 1997;27(5):1011-1019.
24. Russo J, Katon W, Sullivan M, et al. Severity of somatization and its relationship to psychiatric disorders and personality. Psychosomatics. 1994;35(6):546-556.
25. Kroenke K, Spitzer RL, Williams JB, et al. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Archives of Family Medicine. 1994;3(9):774-779.
26. Croghan TW, Obenchain RL, Crown WE. What does treatment of depression really cost? Health Affairs. 1998;17(4):198-208.
27. Howland RH. General health, health care utilization, and medical comorbidity in dysthymia. International Journal of Psychiatric Medicine. 1993;23(3):211-238.
28. Johnson J, Weissman MM, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. Journal of the American Medical Association. 1992;267(11):1478-1483.
29. Sturm R. Economic grand rounds: the myth of medical cost offset. Psychiatric Services. 2001;52(6):738-740.
30. Sturm R. Tracking changes in behavioral health services: how have carve-outs changed care? The Journal of Behavioral Health Services & Research. 1999;26:360-371.
31. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. Journal of the American Medical Association. 2000;283(2):212-220.
32. Pincus HA, Zarin DA, Tanielian TL, et al. Psychiatric patients and treatments in 1997: findings from the American Psychiatric Practice Research Network. Archives of General Psychiatry. 1999;56(5):441-449.
33. Gill D, Hatcher S. A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness. Journal of Psychosomatic Research. 1999;47(2):131-143.
34. Olfson M, Marcus SC, Pincus HA. Trends in office-based psychiatric practice. American Journal of Psychiatry. 1999;156(3):451-457.
35. Olfson M, Marcus SC, Pincus HA, et al. Antidepressant prescribing practices of outpatient psychiatrists. Archives of General Psychiatry. 1998;55(4):310-316.
36. Foote SM, Etheredge L. Increasing use of new prescription drugs: a case study. Health Affairs (Millwood). 2000;19(4):165-170.
37. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. Journal of the American Medical Association. 2002;287(2):203-209.
38. US Department of Health and Human Services. Mental Health: A Report of the Surgeon General. Rockville, MD: Department of Health and Human Services; 1999.
39. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. The New England Journal of Medicine. 2000;342(20):1462-1470.
40. Wells K, Roger W, Bumam MA, et al. How the medical comorbidity of depressed patients differs across health care settings: results from the medical outcomes study. American Journal of Psychiatry. 1991;148(12):1688-1696.
41. Duan N, Manning WG, Morris CN, Newhouse JP. A comparison of alternative models for the demand of medical care. J Econ Business Statistics. 1983;1:115-126.
42. Edgington ES. Randomization Tests. 2nd ed. New York: Marcel Decker; 1987.
43. Hohmann AA, Larson DB, Thompson JW, et al. Psychotropic medication prescription in US ambulatory medical care. DICP. 1991;25(1):85-89.
44. Young AS, Klap R, Sherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Archives of General Psychiatry. 2001;58(1):55-61.
45. Rost K, Nutting PA, Smith J, Werner JJ. Designing and implementing a primary care intervention trial to improve the quality and outcome of care for major depression. General Hospital Psychiatry. 2000;22(2):66-77.
46. Olfson M, Sing M, Schlesinger HJ. Mental health/medical care cost offsets: opportunities for managed care. Health Affairs (Millwood). 1999;18(2):79-90.
47. Sturm R, Klap R. Use of psychiatrists, psychologists and master's-level therapists in managed behavioral health care carve-out plans. Psychiatric Services. 1998;50(4):504-508.
48. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma-United States, 1960-1995. Mortality Weekly Report CDC Surveillance Summary. 1998;47(1):1-27.
49. National Institutes of Health. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Md: National Institutes of Health; 1997.
50. Walker EA, Katon W, Hansom J, et al. Psychiatric diagnoses and sexual victimization in women with chronic pelvic pain. Psychosomatics. 1995;36:531-540.
51. American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorder (revision). American Journal of Psychatry. April 2000;157(suppl):1-45.
52. Agency for Health Care Policy and Research. Depression guideline panel: clinical practice guideline, 5. Depression in Primary Care, Volume 2: Treatment of Major Depression. Rockville, Md: AHCPR publication 93-0551.